G
Modification P00004 SPE2D2-21-D-0131 No Cost-Settlement Termination for Convenience.
Modification P00003 SPE2D2-21-D-0131 to incorporate FAR Claluse 52.204-27 Prohibition on a Bytedance Covered Application (JUN 2023) into contract.
Option Year 2 P00002 SPE2D2-21-D-0131 to invoke option period of April 05, 2023 through April 04, 2024.
Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023.
Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT.
Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.